SLC7A11 and cancer: Therefore, SLC7A11 indirectly counteracts the polyunsaturated fatty acids oxidation enhancing the resistance to ferroptosis induced by anti-cancer drugs (Lin et al., 2020; Jyotsana et al., 2022).